OLDSMAR, Fla., April 13, 2010 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTCBB:CCEL) (the "Company"), one of the world's largest and most established family cord blood banks, today announced results for the first quarter ended February 28, 2010. Consolidated revenues for the first quarter of fiscal 2010 were approximately $4.2 million compared to approximately $4.3 million for the first quarter of fiscal 2009. The revenues for the first quarter of fiscal 2010 consisted of approximately $3.8 million in processing and storage fee revenue and approximately $447,000 in licensee income compared to approximately $3.9 million in processing and storage fee revenue and approximately $390,000 in licensee income for the same period in fiscal 2009. Licensee income for the three months ended February 28, 2010 principally consisted of approximately $292,000 in royalty income earned on the processing and storage of cord blood stem cell specimens in geographic areas where the Company has license agreements. The remaining 2010 licensee income related to installment payments of non-refundable up-front license fees from the licensees of the Company's U-Cord program in Chile, Colombia, Peru, Nicaragua and Pakistan. Licensee income for the 2009 period consisted of approximately $290,000 in royalty income earned on the processing and storage of specimens in geographical areas where the Company has license agreements. The remaining 2009 licensee income related to an installment payment of a non-refundable up-front license fee from the licensee of the Company's U-Cord program in Venezuela.
